Serum Uric Acid and Iron Status: Exploring a Complex Interaction in Metabolic Syndrome Patients of Eastern India

Overview

Journal Cureus

Specialty Biomedical Engineering

Date 2024 Nov 4

PMID 39493039

Authors

Saumyajit Maiti

Sudipa Pal

Debabrata Chatterjee

Arkajit Dasgupta

Amrit Podder

Affiliations

Soon will be listed here.

Abstract

Background: Metabolic syndrome, a cluster of illnesses including insulin resistance, hyperlipidemia, hypertension, and central obesity, is affecting roughly a quarter of the world population. Dysregulation of iron homeostasis may be associated with insulin resistance, leading to metabolic syndrome. Uric acid is an antioxidant currently studied in relation to several metabolic disorders. It may also be interlinked with iron metabolism. Yet, data regarding the interplay between serum iron, ferritin, and uric acid in metabolic syndrome are scarce. Hence, this study aimed to identify any alteration of serum iron, ferritin, and uric acid levels in metabolic syndrome patients of Eastern India and to explore any inter-relationship between these parameters. Methodology: A cross-sectional observational study including 103 patients suffering from metabolic syndrome and 107 age- and sex-matched healthy individuals was conducted. Subjects were evaluated for serum iron, ferritin, and uric acid levels, besides the diagnostic parameters of metabolic syndrome.

Results: Metabolic syndrome cases had higher serum iron, ferritin, and uric acid levels as compared to the controls. Serum uric acid was positively correlated with both iron and ferritin.

Conclusion: Metabolic syndrome is associated with elevated serum levels of iron, ferritin, and uric acid. Iron overload, reflected in elevated serum ferritin, can cause oxidative stress and endothelial damage, thereby predisposing to metabolic and vascular complications. Uric acid, an antioxidant, can rise in an attempt to counter oxidative stress. Metabolic syndrome patients should be periodically assessed for iron profile and uric acid to design suitable treatment protocols for better management of disease progression and alleviation of complications.

References

Saklayen M . The Global Epidemic of the Metabolic Syndrome. Curr Hypertens Rep. 2018; 20(2):12. PMC: 5866840. DOI: 10.1007/s11906-018-0812-z. View

Al Akl N, Khalifa O, Errafii K, Arredouani A . Association of dyslipidemia, diabetes and metabolic syndrome with serum ferritin levels: a middle eastern population-based cross-sectional study. Sci Rep. 2021; 11(1):24080. PMC: 8677797. DOI: 10.1038/s41598-021-03534-y. View

Fernandez-Real J, Lopez-Bermejo A, Ricart W . Cross-talk between iron metabolism and diabetes. Diabetes. 2002; 51(8):2348-54. DOI: 10.2337/diabetes.51.8.2348. View

Wang H, Li H, Jiang X, Shi W, Shen Z, Li M . Hepcidin is directly regulated by insulin and plays an important role in iron overload in streptozotocin-induced diabetic rats. Diabetes. 2014; 63(5):1506-18. DOI: 10.2337/db13-1195. View

Khan Y, Lalchandani A, Gupta A, Khadanga S, Kumar S . Prevalence of metabolic syndrome crossing 40% in Northern India: Time to act fast before it runs out of proportions. J Family Med Prim Care. 2018; 7(1):118-123. PMC: 5958552. DOI: 10.4103/jfmpc.jfmpc_10_17. View

Ma W, Yang C, Shih S, Hsieh H, Hung C, Chiu F . Measurement of Waist Circumference: midabdominal or iliac crest?. Diabetes Care. 2013; 36(6):1660-6. PMC: 3661855. DOI: 10.2337/dc12-1452. View

Fillebeen C, Lam N, Chow S, Botta A, Sweeney G, Pantopoulos K . Regulatory Connections between Iron and Glucose Metabolism. Int J Mol Sci. 2020; 21(20). PMC: 7589414. DOI: 10.3390/ijms21207773. View

Biswas S, Tapryal N, Mukherjee R, Kumar R, Mukhopadhyay C . Insulin promotes iron uptake in human hepatic cell by regulating transferrin receptor-1 transcription mediated by hypoxia inducible factor-1. Biochim Biophys Acta. 2012; 1832(2):293-301. DOI: 10.1016/j.bbadis.2012.11.003. View

Ford E, Li C, Cook S, Choi H . Serum concentrations of uric acid and the metabolic syndrome among US children and adolescents. Circulation 115: 2526-2532, 2007. Clin J Am Soc Nephrol. 2023; 3(2):317-323. DOI: 10.2215/01.CJN.0000926948.20608.e5. View

10.

Goh K, Chen C, Wu T, Chen C, Lu M . Crosstalk between Schizophrenia and Metabolic Syndrome: The Role of Oxytocinergic Dysfunction. Int J Mol Sci. 2022; 23(13). PMC: 9266532. DOI: 10.3390/ijms23137092. View

11.

Fang Y, Mei W, Wang C, Ren X, Hu J, Su F . Dyslipidemia and hyperuricemia: a cross-sectional study of residents in Wuhu, China. BMC Endocr Disord. 2024; 24(1):2. PMC: 10759755. DOI: 10.1186/s12902-023-01528-7. View

12.

Aigner E, Felder T, Oberkofler H, Hahne P, Auer S, Soyal S . Glucose acts as a regulator of serum iron by increasing serum hepcidin concentrations. J Nutr Biochem. 2012; 24(1):112-7. DOI: 10.1016/j.jnutbio.2012.02.017. View

13.

Zhu L, Spence C, Yang J, Ma G . The IDF Definition Is Better Suited for Screening Metabolic Syndrome and Estimating Risks of Diabetes in Asian American Adults: Evidence from NHANES 2011-2016. J Clin Med. 2020; 9(12). PMC: 7759813. DOI: 10.3390/jcm9123871. View

14.

Cuschieri S . The STROBE guidelines. Saudi J Anaesth. 2019; 13(Suppl 1):S31-S34. PMC: 6398292. DOI: 10.4103/sja.SJA_543_18. View

15.

Kuwabara M, Fukuuchi T, Aoki Y, Mizuta E, Ouchi M, Kurajoh M . Exploring the Multifaceted Nexus of Uric Acid and Health: A Review of Recent Studies on Diverse Diseases. Biomolecules. 2023; 13(10). PMC: 10604821. DOI: 10.3390/biom13101519. View

16.

Volani C, Doerrier C, Demetz E, Haschka D, Paglia G, Lavdas A . Dietary iron loading negatively affects liver mitochondrial function. Metallomics. 2017; 9(11):1634-1644. DOI: 10.1039/c7mt00177k. View

17.

Li X, He T, Yu K, Lu Q, Alkasir R, Guo G . Markers of Iron Status Are Associated with Risk of Hyperuricemia among Chinese Adults: Nationwide Population-Based Study. Nutrients. 2018; 10(2). PMC: 5852767. DOI: 10.3390/nu10020191. View

18.

Tan C, Sasagawa Y, Kamo K, Kukitsu T, Noda S, Ishikawa K . Evaluation of the Japanese Metabolic Syndrome Risk Score (JAMRISC): a newly developed questionnaire used as a screening tool for diagnosing metabolic syndrome and insulin resistance in Japan. Environ Health Prev Med. 2016; 21(6):470-479. PMC: 5112197. DOI: 10.1007/s12199-016-0568-5. View